Table: Hisamitsu - 9-MTH group results
Jan 11 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Nov 30, 2018 Nov 30, 2017 Feb 28, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 102.57 109.55 148.50
(-6.4 pct) (-0.2 pct) (+0.4 pct)
Operating 15.94 20.69 24.00
(-22.9 pct) (-5.9 pct) (-8.9 pct)
Recurring 17.41 22.04 26.30
(-21.0 pct) (-3.7 pct) (-6.9 pct)
Net 13.33 15.84 19.20
(-15.8 pct) (-13.6 pct) (+0.4 pct)
EPS 159.35 yen 189.33 yen 229.53 yen
EPS Diluted 159.20 yen 189.19 yen
Ann Div 82.00 yen 82.50 yen
-Q2 div 41.25 yen 41.00 yen
-Q4 div 41.00 yen 41.25 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO